vaccine

Groundbreaking melanoma vaccine could be available in just two years – ScienceAlert

Moderna CEO Stephane Bancel told AFP that his company’s experimental vaccine against melanoma could be available in just two years, amounting to a groundbreaking step against the most serious form of skin cancer. Globally, there were an estimated 325,000 new cases of melanoma and 57,000 deaths from the disease in 2020. “We expect that the … [Read more…]

Moderna and Merck's Keytruda vaccine delays recurrence of deadly skin cancer after three years, data says

These results are based on medium-sized trial data the companies released earlier this year that showed the combination’s effectiveness in the same 157 patients over a shorter period of time. After about two years, the vaccine and Keytruda reduced the risk of death or recurrence in melanoma patients by 44% and the risk of the … [Read more…]